1)  anticancer agent
抗癌试剂
1.
Novel 2,3-disubstituted indoles as anticancer agents in total yield of 33%~37% were synthesized from o-iodoaniline and phenylethyne by ten-steps reaction.
以邻碘苯胺和苯乙炔为原料,经10步反应合成了2,3-二取代的新型吲哚抗癌试剂,总收率33%~37%,其结构经1H NMR和MS表征。
2)  anti-cancer
抗癌
1.
Research on the CYP 1B1 Inhibitors as Anti-cancer Drugs;
抗癌药细胞色素P4501B1抑制剂的研究进展
2.
Functional Genomics, Proteomics, and the Mechanism of Liver Protection and Anti-cancer of Cordyceps Sinensis;
功能基因体学蛋白质体学与冬虫夏草之保肝抗癌机制
3.
A summary of studies on anti-cancer plant resources and natural products;
抗癌植物资源与天然产物研究
3)  Antitumor
抗癌
1.
Preparation of Antitumor Compound—— 20(S)- Protopanaxidiol by the Method of Alkali Catalyzing Degradation;
碱催化降解法制备抗癌活性化合物20(S)-原人参二醇
2.
Antitumor researches of a medicinal mushroom——phellinus sp;
药用真菌桑黄(phellinus sp.)抗癌功能的研究进展
3.
Synthesis and antitumor,anti inflammatory and analgesic activities of (E) -2-(un)substituted benzylidene -6- ((alkylamino)methyl)-1-aryl cyclohexanols;
2-(E)-取代苯亚甲基-6-取代胺甲基-1-取代苯基环己醇类化合物的合成及抗炎镇痛、抗癌活性研究
4)  Anticancer Activity
抗癌
1.
Aim To isolate a kind of cytotoxin from GuangXi Agkistrodon acutus Venom andprimaryly investigate its anticancer activity in vitro.
目的分离广西五步蛇(Agkistrodon acutus)蛇毒细胞毒素,并初步探讨其体外抗癌活性。
5)  anticancer
抗癌
1.
Studies on the anticancer drug bonding porphyrin;
金属卟啉介导抗癌药物研究
2.
Syntheses and Structure-activity Relationship of Podophyllotoxin Derivatives as Potential Anticancer Drugs;
抗癌活性鬼臼毒素衍生物的合成与构效关系研究
3.
Recent progress of the porphyrin-based anticancer drugs;
卟啉类抗癌药物研究新进展
6)  Anti-tumor
抗癌
1.
The anti free-radical,antihyperglycemic and anti-tumor effect of the fleshy fruit(EFF) and fleshy leaf(EFY) extract on Camellia oleifera Abel were investigated.
研究油茶肉质果、肉质叶提取液(EFF,EFY)的抗自由基、降血糖和抗癌作用。
2.
Anti-tumor activities were tested with tumor-model in.
目的 为研制低毒高效的抗癌制剂 ,确定不同的白花蛇舌草提取物 (汤剂、亲脂提取物、粗多糖 )的抗肿瘤作用。
3.
Preliminary result showed that two stable nitrogen-oxygen free radicals platinum complexes had anti-tumor activity and their toxicity was lower than that of cisplatin.
将稳定氮氧自由基引入抗癌药物顺铂中,合成了二种新的稳定氮氧自由基铂配合物,通过红外光谱、质谱、元素分析确定了其结构,初步结果显示二种稳定氮氧自由基铂配合物有抗癌活性,毒性比母体化合物(顺铂)低。
参考词条
补充资料:氨基酸类抗癌药物
分子式:暂无
分子量:暂无
CAS号:暂无

性质:暂无

制备方法:暂无

用途:暂无

说明:补充资料仅用于学习参考,请勿用于其它任何用途。